Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: Photo/Multimedia, Event, Product/Service, Conference Call

Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting


Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientifictm DynaSpintm Single-Use Centrifuge system at the BioProcess International annual conference in Boston, MA. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. The DynaSpin system improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process. The DynaSpin solution delivers equivalent or improved product yield compared to traditional harvest systems while enabling operational efficiency, cost savings and sustainable practices in the production of biologics.

The DynaSpin system helps reduce overall production costs while allowing biologic manufacturers to support their sustainability goals. By reducing the number of filters required for harvesting, this product offers upwards of six-fold reduction in material requirements, eliminating 70% of waste compared to traditional harvest systems.

"We developed the DynaSpin system with an eye on efficiently harvesting biologics at large-scale, such as from our 5,000-liter Thermo Scientific DynaDrive Bioreactor," said Srini Paluri, vice president & general manager, Thermo Fisher Scientific's bioproduction business. "It was critical that the solution also consider the environment while outperforming traditional harvest solutions and delivering consistent product yields to our customers. The DynaSpin technology meets these objectives and will help our customers provide greater accessibility of therapeutics and vaccines globally."

In addition to the optimized design and smaller equipment footprint, the DynaSpin system incorporates the well-documented advantages of single-use products including scalability, rapid change over, reduced downtime and lower risk of contamination to the workflow. The ergonomic design of the system provides ease of access for system operation and maintenance, including loading and unloading the single-use rotor and line set assembly. DynaSpin brings automation technology not previously available in single-use solutions for harvesting. It provides configurable user access, audit trail and batch reporting, allowing the users to meet 21 CFR Part 11 compliance.

The DynaSpin Centrifuge system will be available to order in the fourth quarter of 2022. Please visit www.thermofisher.com/dynaspin for more information about the DynaSpin Centrifuge system.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.


These press releases may also interest you

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...

at 07:02
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's...

at 07:01
101 Mobility, a leading provider of mobility and accessibility solutions, is thrilled to announce the return of Chris Diehl to its Home Office Team. Chris rejoins 101 Mobility in the role of Director of National Accounts, where he will focus on...



News published on and distributed by: